Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin

Ralph A. DeFronzo, Andrew Lewin, Sanjay Patel, Dacheng Liu, Renee Kaste, Hans J. Woerle, Uli C. Broedl

Research output: Contribution to journalArticlepeer-review

209 Scopus citations

Fingerprint

Dive into the research topics of 'Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin'. Together they form a unique fingerprint.

Medicine & Life Sciences